RemeGen , Ltd. Current Assets

The latest current assets for REGMF is $6.6B as of June 2026. That compares with $2.7B in the prior-year period — up 145.4% year over year. Investors often review this figure alongside RemeGen , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, REGMF's current assets moved from $2.7B to $6.6B — a 145.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in RemeGen , Ltd.'s operating scale or balance-sheet position.

A current assets figure of $6.6B for REGMF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting REGMF's current assets ($6.6B), review year-over-year change from $2.7B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack RemeGen , Ltd.'s current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.